Efficacy of ruxolitinib in B-lymphoblastic leukaemia with the PCM1-JAK2 fusion gene

被引:7
|
作者
Wouters, Yannick [1 ,2 ]
Nevejan, Louis [3 ]
Louwagie, Annelies [2 ]
Devos, Helena [3 ]
Dewaele, Barbara [4 ,5 ]
Selleslag, Dominik [6 ]
Michaux, Lucienne [4 ,5 ]
机构
[1] Sint Franciscus Hosp, Dept Lab Med, Heusden Zolder, Belgium
[2] Univ Hosp Leuven, Dept Lab Med, Leuven, Belgium
[3] AZ Sint Jan Hosp Brugge Oostende, Dept Lab Med, Brugge, Belgium
[4] Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium
[5] Katholieke Univ Leuven, Leuven, Belgium
[6] AZ Sint Jan Hosp Brugge Oostende, Dept Hematol, Brugge, Belgium
关键词
PCM1‐ JAK2; ruxolitinib; B‐ ALL; t(8; 9); PCM1; NEOPLASMS; JAK2;
D O I
10.1111/bjh.17340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e112 / e115
页数:4
相关论文
共 50 条
  • [21] PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation
    Murati, A
    Gelsi-Boyer, V
    Adélaïde, J
    Perot, C
    Talmant, P
    Giraudier, S
    Lodé, L
    Letessier, A
    Delaval, B
    Brunel, V
    Imbert, M
    Garand, R
    Xerri, L
    Birnbaum, D
    Mozziconacci, M
    Chaffanet, M
    LEUKEMIA, 2005, 19 (09) : 1692 - 1696
  • [22] A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma
    Adélaïde, J
    Pérot, C
    Gelsi-Boyer, V
    Pautas, C
    Murati, A
    Copie-Bergman, C
    Imbert, M
    Chaffanet, M
    Birnbaum, D
    Mozziconacci, MJ
    LEUKEMIA, 2006, 20 (03) : 536 - 537
  • [23] PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation
    A Murati
    V Gelsi-Boyer
    J Adélaïde
    C Perot
    P Talmant
    S Giraudier
    L Lodé
    A Letessier
    B Delaval
    V Brunel
    M Imbert
    R Garand
    L Xerri
    D Birnbaum
    M J Mozziconacci
    M Chaffanet
    Leukemia, 2005, 19 : 1692 - 1696
  • [24] Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2
    Luedke, Catherine
    Rein, Lindsay
    BLOOD, 2020, 136 (09) : 1113 - 1113
  • [25] Identification of a novel GOLGA4-JAK2 fusion gene in B-cell acute lymphoblastic leukaemia
    Downes, Charlotte E. J.
    Rehn, Jacqueline
    Heatley, Susan L.
    Yeung, David
    McClure, Barbara J.
    White, Deborah L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 700 - 705
  • [26] Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1
    Patterer, Verena
    Schnittger, Susanne
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    ANNALS OF HEMATOLOGY, 2013, 92 (06) : 759 - 769
  • [27] Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1
    Verena Patterer
    Susanne Schnittger
    Wolfgang Kern
    Torsten Haferlach
    Claudia Haferlach
    Annals of Hematology, 2013, 92 : 759 - 769
  • [29] Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes
    Schwaab, Juliana
    Naumann, Nicole
    Luebke, Johannes
    Jawhar, Mohamad
    Somervaille, Tim C. P.
    Williams, Mark S.
    Frewin, Rebecca
    Jost, Philipp J.
    Lichtenegger, Felix S.
    La Rosee, Paul
    Storch, Nicola
    Haferlach, Torsten
    Horny, Hans-Peter
    Fabarius, Alice
    Haferlach, Claudia
    Burchert, Andreas
    Hofmann, Wolf-Karsten
    Cross, Nicholas C. P.
    Hochhaus, Andreas
    Reiter, Andreas
    Metzgeroth, Georgia
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (07) : 824 - 833
  • [30] Erythrophagocytosis by blast cells in B-lymphoblastic leukaemia with BCR-ABL1
    Amparo Pimentel-Villar, M.
    Morales-Camacho, Rosario M.
    Teresa Vargas, M.
    Jimenez-Jambrina, Margarita
    Martin-Chacon, Eusebio
    Prats-Martin, Concepcion
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (01) : 7 - 7